neurodegenerative diseases

neurodegenerative diseases

diseases characterized by neurodegeneration. Lesions are microscopic only but in chronic disease with massive involvement there may be grossly visible atrophy of affected nervous tissue.
References in periodicals archive ?
LONDON, July 13, 2015 /PRNewswire/ -- About neurodegenerative diseases According to the EU JPND, neurodegenerative diseases refer to conditions that involve the neurons in the brain.
com/research/rf4hfn/global) has announced the addition of the "Global Neurodegenerative Diseases Market 2015-2019" report to their offering.
For example, the incidence of certain neurodegenerative diseases among people living in the Asian subcontinent, where people regularly consume spices, is much lower than in countries of the western world.
Parkinson disease (PD) and Alzheimer disease (AD) are the two most common neurodegenerative diseases of the older American population.
The Woodlands, TX) entered into a research agreement with The Methodist Hospital Research Institute to search for biomarkers and develop a suite of tests that directly impact the diagnosis of neurodegenerative diseases.
Arising from this research to date has been the development of Prana's MPAC platform technology and the identification of other therapeutic approaches with exciting promise for the treatment of Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases.
A half dozen or so neurodegenerative diseases stem from an excess of CAG repeats.
This special focus issue provides an overview of current themes and significant advances in the identification and modulation of molecular targets, pathways and aggregation in both chronic and acute neurodegenerative diseases.
The Global Neurodegenerative Diseases Market 2015-2019 research report says reformulation of marketed drugs is boosting the growth of neurodegenerative diseases market during the period reviewed for forecasts in this research.
This review provides an overview of the epidemiologic evidence for environmental etiologies for neurodegenerative diseases such as Alzheimer disease, Parkinson disease, parkinsonian syndromes (multiple system atrophy and progressive supranuclear palsy), and amyotrophic lateral sclerosis.
Upon execution of the final agreement, the principal goals of the research program will be to advance the functional understanding of an undisclosed UOM protein in neurodegenerative diseases by researching its signaling pathways.
To determine whether the mutant mRNAs were specific to ALS, Rothstein's group examined brain and spinal cord tissue from 24 people who had died of other neurodegenerative diseases or non-neurological causes.